While EMT in cell culture models is characterized by simultaneous up- and downregulation of markers such as vimentin, N-cadherin and E-cadherin, it is not known whether synchronous expression also occurs within cell populations undergoing EMT in clinical PCa. The gene discussed is CDH2; the disease is posterior cortical atrophy.